JP2007506698A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007506698A5 JP2007506698A5 JP2006527359A JP2006527359A JP2007506698A5 JP 2007506698 A5 JP2007506698 A5 JP 2007506698A5 JP 2006527359 A JP2006527359 A JP 2006527359A JP 2006527359 A JP2006527359 A JP 2006527359A JP 2007506698 A5 JP2007506698 A5 JP 2007506698A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- acid addition
- addition salt
- free base
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims 11
- 239000002253 acid Substances 0.000 claims 8
- 239000012458 free base Substances 0.000 claims 7
- 238000004519 manufacturing process Methods 0.000 claims 7
- 101001032845 Homo sapiens Metabotropic glutamate receptor 5 Proteins 0.000 claims 3
- 102100038357 Metabotropic glutamate receptor 5 Human genes 0.000 claims 3
- 210000000133 brain stem Anatomy 0.000 claims 3
- 238000000338 in vitro Methods 0.000 claims 3
- 238000001727 in vivo Methods 0.000 claims 3
- 238000002372 labelling Methods 0.000 claims 3
- 210000001428 peripheral nervous system Anatomy 0.000 claims 3
- 238000002360 preparation method Methods 0.000 claims 3
- 239000002585 base Substances 0.000 claims 2
- 238000002610 neuroimaging Methods 0.000 claims 2
- 210000005013 brain tissue Anatomy 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003550 marker Substances 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- ACZNCLRHSFNGTB-UHFFFAOYSA-N 3-[2-(6-methylpyridin-2-yl)ethynyl]cyclohex-2-en-1-one Chemical compound CC1=CC=CC(C#CC=2CCCC(=O)C=2)=N1 ACZNCLRHSFNGTB-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- -1 3- (6-Methyl-pyridin-2-ylethynyl) -cyclohex-2-enone 2-Ethynyl-6-methyl-pyridine Chemical compound 0.000 description 1
- BVSMYYHGYVHWCD-UHFFFAOYSA-N 3-bromocyclohex-2-en-1-one Chemical compound BrC1=CC(=O)CCC1 BVSMYYHGYVHWCD-UHFFFAOYSA-N 0.000 description 1
- PQRQIJJBPGOPOG-UHFFFAOYSA-N CC1=CC=CC(=N1)C#CC1=CC(CCC1)=O.CC1=CC=CC(=N1)C#CC1=CC(CCC1)=NO Chemical compound CC1=CC=CC(=N1)C#CC1=CC(CCC1)=O.CC1=CC=CC(=N1)C#CC1=CC(CCC1)=NO PQRQIJJBPGOPOG-UHFFFAOYSA-N 0.000 description 1
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- YNHIGQDRGKUECZ-UHFFFAOYSA-N dichloropalladium;triphenylphosphanium Chemical compound Cl[Pd]Cl.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-N 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0322612.3 | 2003-09-26 | ||
| GBGB0322612.3A GB0322612D0 (en) | 2003-09-26 | 2003-09-26 | Organic compounds |
| PCT/EP2004/010743 WO2005030723A1 (en) | 2003-09-26 | 2004-09-24 | Pyridylacetylenes for use as radiotracers and imaging agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007506698A JP2007506698A (ja) | 2007-03-22 |
| JP2007506698A5 true JP2007506698A5 (enExample) | 2011-07-28 |
| JP4965255B2 JP4965255B2 (ja) | 2012-07-04 |
Family
ID=29286926
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006527359A Expired - Fee Related JP4965255B2 (ja) | 2003-09-26 | 2004-09-24 | 放射性トレーサーおよび造影剤として使用するピリジルアセチレン類 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US8674110B2 (enExample) |
| EP (1) | EP1670762B1 (enExample) |
| JP (1) | JP4965255B2 (enExample) |
| CN (1) | CN100430380C (enExample) |
| AU (2) | AU2004275971B2 (enExample) |
| BR (1) | BRPI0414732A (enExample) |
| CA (1) | CA2539469C (enExample) |
| ES (1) | ES2400713T3 (enExample) |
| GB (1) | GB0322612D0 (enExample) |
| MX (1) | MXPA06003424A (enExample) |
| PL (1) | PL1670762T3 (enExample) |
| PT (1) | PT1670762E (enExample) |
| WO (1) | WO2005030723A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0525068D0 (en) | 2005-12-08 | 2006-01-18 | Novartis Ag | Organic compounds |
| US8349852B2 (en) | 2009-01-13 | 2013-01-08 | Novartis Ag | Quinazolinone derivatives useful as vanilloid antagonists |
| WO2011092293A2 (en) | 2010-02-01 | 2011-08-04 | Novartis Ag | Cyclohexyl amide derivatives as crf receptor antagonists |
| AR080055A1 (es) | 2010-02-01 | 2012-03-07 | Novartis Ag | Derivados de pirazolo-[5,1-b]-oxazol como antagonistas de los receptores de crf -1 |
| CN102753527B (zh) | 2010-02-02 | 2014-12-24 | 诺华股份有限公司 | 用作crf受体拮抗剂的环己基酰胺衍生物 |
| CN103097391B (zh) | 2010-07-09 | 2015-04-08 | 雷科尔达蒂爱尔兰有限公司 | 作为mGlu5拮抗剂的新型螺环杂环化合物 |
| US8546416B2 (en) | 2011-05-27 | 2013-10-01 | Novartis Ag | 3-spirocyclic piperidine derivatives as ghrelin receptor agonists |
| AU2013255458A1 (en) | 2012-05-03 | 2014-10-09 | Novartis Ag | L-malate salt of 2, 7 - diaza - spiro [4.5 ] dec- 7 - yle derivatives and crystalline forms thereof as ghrelin receptor agonists |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6843979B2 (en) | 1999-04-26 | 2005-01-18 | Emory University | 4-haloethenylphenyl tropane:serotonin transporter imaging agents |
| EP1048302A3 (en) | 1999-04-30 | 2002-07-17 | Pfizer Products Inc. | Radiotracers for in vivo study of acetylcholinesterase and Alzheimer's disease |
| AU5613900A (en) * | 1999-06-30 | 2001-01-31 | Sun Microsystems, Inc. | Customizing web content based on network conditions |
| JP4815083B2 (ja) | 1999-08-31 | 2011-11-16 | メルク・シャープ・エンド・ドーム・コーポレイション | 複素環化合物およびそれの使用方法 |
| GB0103045D0 (en) * | 2001-02-07 | 2001-03-21 | Novartis Ag | Organic Compounds |
| JP4070431B2 (ja) | 2001-07-10 | 2008-04-02 | ジーイー・ヘルスケア・リミテッド | モノアミン再取込み部位のマッピング用ヨウ素付加神経プローブ |
| EP1556142A4 (en) | 2002-10-24 | 2006-11-08 | Merck & Co Inc | ALKYN DERIVATIVES AS TRACERS FOR THE METABOTROPE GLUTAMATE RECEPTOR BINDING |
-
2003
- 2003-09-26 GB GBGB0322612.3A patent/GB0322612D0/en not_active Ceased
-
2004
- 2004-09-24 MX MXPA06003424A patent/MXPA06003424A/es active IP Right Grant
- 2004-09-24 US US10/573,162 patent/US8674110B2/en not_active Expired - Fee Related
- 2004-09-24 AU AU2004275971A patent/AU2004275971B2/en not_active Ceased
- 2004-09-24 BR BRPI0414732-4A patent/BRPI0414732A/pt not_active IP Right Cessation
- 2004-09-24 CN CNB2004800273094A patent/CN100430380C/zh not_active Expired - Fee Related
- 2004-09-24 ES ES04765586T patent/ES2400713T3/es not_active Expired - Lifetime
- 2004-09-24 CA CA2539469A patent/CA2539469C/en not_active Expired - Fee Related
- 2004-09-24 EP EP04765586A patent/EP1670762B1/en not_active Expired - Lifetime
- 2004-09-24 PL PL04765586T patent/PL1670762T3/pl unknown
- 2004-09-24 WO PCT/EP2004/010743 patent/WO2005030723A1/en not_active Ceased
- 2004-09-24 PT PT47655865T patent/PT1670762E/pt unknown
- 2004-09-24 JP JP2006527359A patent/JP4965255B2/ja not_active Expired - Fee Related
-
2008
- 2008-12-23 AU AU2008261192A patent/AU2008261192B2/en not_active Ceased
-
2014
- 2014-01-24 US US14/162,885 patent/US20140142318A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006513278A5 (enExample) | ||
| CN109879733B (zh) | 一种单氟溴代丙酮衍生物的合成方法 | |
| JP2007506698A5 (enExample) | ||
| JP4965255B2 (ja) | 放射性トレーサーおよび造影剤として使用するピリジルアセチレン類 | |
| CN111662147B (zh) | 制备二炔及其类似物的方法 | |
| CN116082181A (zh) | 一种制备3-氨基-5-乙氧基-苯甲酸的方法 | |
| JP2004528380A (ja) | ゾルピデムの製造方法 | |
| CN113999201A (zh) | 一种烟碱的合成制备方法 | |
| JP2009249355A (ja) | フッ素化されたフルオレン誘導体およびその製造方法 | |
| CN110590641B (zh) | 一种3-羟基异吲哚-1-酮系列化合物的绿色制备方法 | |
| CN114436950B (zh) | 使用芳基烷基氨基锂作为大位阻碱的酯基烷基化方法 | |
| KR20160051246A (ko) | 4－((3－아미노－2－히드록시프로필)－아미노카보닐)－페닐보로닉산의 제조 방법 | |
| CN120289364B (zh) | N-烷氧基季铵盐类手性催化剂及其在氢原子转移和烷基化反应中的应用 | |
| CN112778261B (zh) | 一种银催化合成异香豆素类衍生物的方法及其应用 | |
| CN114573489B (zh) | 一种卡前列素的分离方法 | |
| JPH0543709B2 (enExample) | ||
| JP3230723B2 (ja) | ２−（フルフリルチオ）酢酸誘導体の製造方法 | |
| CN105330687B (zh) | Poss支载c2对称的双脯胺酰胺及其制备方法和用途 | |
| CN107556269B (zh) | α-炔基取代醚类化合物的合成方法 | |
| CN115784934A (zh) | 一种酪氨酸衍生物的合成方法 | |
| JPS5840939B2 (ja) | シクロヘキサンジオン誘導体の製造方法 | |
| CN118812501A (zh) | 一种硫辛酸的制备方法 | |
| CN118652285A (zh) | 一种三取代二茂铁衍生物的制备方法 | |
| CN103804278B (zh) | 一种天然产物2-甲基-3-甲氧基-咔唑-1,4-苯醌的制备方法 | |
| CN104030997B (zh) | 一种用于埃索美拉唑不对称合成的催化剂 |